Current Assets

CVS Health·Balance Sheet Statement·16 metrics

Breakdown

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Total current assets	$70B	$67.3B	$68.6B	$73.2B	$75.6B	$77.1B	$74.7B	$74.8B
Accounts receivable, net	$32.4B	$36.2B	$36.5B	$39.6B	$40.7B	$43.9B	$39.8B	$41B
Inventories	$16.1B	$17.6B	$18.1B	$17.4B	$17.4B	$19B	$19.2B	$17.8B
AFS and Trading Securities - Unrealized Loss Position Fair Value	$15B	$7.5B	$13.2B	$9.9B	$6.6B	$5.4B	$6.3B	$12.8B
Contract assets	$9.8B	$9.9B	$9.9B	$10.5B	$10.5B	$11.2B	$10.6B	$12.5B
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$6B	$871M	$7.5B	$4.9B	$2.5B	$1.8B	$2.9B	$10.1B
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$6B	$871M	$7.5B	$4.9B	$2.5B	$1.8B	$2.9B	$10.1B
Cash and cash equivalents	$12.8B	$7.1B	$8.9B	$10.3B	$12B	$9.4B	$8.7B	$9.8B
Premiums receivable	$4.4B	$3.9B	$4.7B	$6.2B	$5.9B	$4.9B	$5.8B	$7.6B
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)	$4.6B	$6.7B	$8B	$8.8B	$9.1B	$10B	$7.9B	$6.7B
Other current assets	$5.2B	$3.8B	$3.1B	$3.5B	$3.4B	$3.1B	$5.1B	$4.3B
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	$9B	$6.6B	$5.7B	$5B	$4.1B	$3.7B	$3.5B	$2.7B
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	$9B	$6.6B	$5.7B	$5B	$4.1B	$3.7B	$3.5B	$2.7B
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	$1.4B	$819M	—	$1.2B	$961M	$835M	—	$850M
Allowance for Doubtful Accounts	$355M	$346M	$407M	$392M	$374M	$178M	$182M	$200M
Restricted cash	$54M	$65M	$95M	$65M	$43M	$57M	$59M	$14M